In the context of the COVID-19 epidemic, caused by the SARS-CoV2 virus, recognized as a serious disease for immediate attention, 1 and considering that the Federal Ministry of Health has announced that Mexico entered into phase 2, the Federal Economic Competition Commission (COFECE or Commission) is aware of the inconveniences this situation may cause to companies, consumers and the general functioning of the markets. To contribute to uninterrupted operation of supply chains or to an artificial restriction of the supply that raises prices of goods and services, the Commission states the following:
Featured News
DOJ Prosecutors Advise Against Criminal Charges in Live Nation Antitrust Probe
Dec 17, 2025 by
CPI
Supreme Court Closes Door on REX Antitrust Case Against Realtors Group
Dec 17, 2025 by
CPI
PepsiCo and Walmart Face Federal Lawsuit Alleging Long-Running Price-Fixing Scheme
Dec 17, 2025 by
CPI
Utah Reaches Antitrust Settlement With Sandoz Over Generic Drug Pricing
Dec 17, 2025 by
CPI
China Regulator Flags ‘Lowest-Price’ Demands as Potential Antitrust Violations
Dec 17, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 16, 2025 by
CPI
Learning from Divergence: The Role of Cross-Country Comparisons in the Evaluation of the DMA
Dec 16, 2025 by
Federico Bruni
New Regulatory Tools for the EU Foreign Direct Investment Screening and Foreign Subsidies Regulation
Dec 16, 2025 by
Ioannis Kokkoris
“Suite Dreams”: Market Definition and Complementarity in the Digital Age
Dec 16, 2025 by
Romain Bizet & Matteo Foschi
The Interaction Between Competition Policy and Consumer Protection: Institutional Design, Behavioral Insights, and Emerging Challenges in Digital Markets
Dec 16, 2025 by
Alessandra Tonazzi